AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Cash from investing

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 20231-409.68%
Mar 31, 2021-0-96.38%
Mar 31, 2020-6+3621.12%
Mar 31, 2019-0-99.74%
Mar 31, 2018-63+1277.06%
Mar 31, 2017-5+2302.11%
Mar 31, 2016-0-96.04%
Mar 31, 2015-5-67.03%
Mar 31, 2014-15+12.87%
Mar 31, 2013-13+77.43%
Mar 31, 2012-7-31.76%
Mar 31, 2011-11+13.80%
Mar 31, 2010-9+263.22%
Mar 31, 2009-3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)